Logo-ipp

Immunopathol Persa. 2020;6(2): e21. doi: 10.34172/ipp.2020.21

Original

Relation between Immune cell response and stemness genes expression in breast cancer; A new approach in NANOG gene and Let7-a expression in breast cancer cell lines

Zeynab Aliyari-Serej 1,2,3 ORCID, Ayyub Ebrahimi 4 ORCID, Tohid Kazemi 2,5 ORCID, Souzan Najafi 2, Elmira Roshani 2, Mohammad Ebrahimi-Kalan 6 ORCID, Behzad Baradaran 2,5 * ORCID

Cited by CrossRef: 6


1- Lotfinejad P, Kazemi T, Safaei S, Amini M, Roshani asl E, Baghbani E, Sandoghchian Shotorbani S, Jadidi Niaragh F, Derakhshani A, Abdoli Shadbad M, Silvestris N, Baradaran B. PD-L1 silencing inhibits triple-negative breast cancer development and upregulates T-cell-induced pro-inflammatory cytokines. Biomedicine & Pharmacotherapy. 2021;138:111436 [Crossref]
2- Ghasemi Darestani N, Gilmanova A, Al-Gazally M, Zekiy A, Ansari M, Zabibah R, Jawad M, Al-Shalah S, Rizaev J, Alnassar Y, Mohammed N, Mustafa Y, Darvishi M, Akhavan-Sigari R. Mesenchymal stem cell-released oncolytic virus: an innovative strategy for cancer treatment. Cell Commun Signal. 2023;21(1) [Crossref]
3- Yang M, Zhang Y, Li M, Liu X, Darvishi M. The various role of microRNAs in breast cancer angiogenesis, with a special focus on novel miRNA-based delivery strategies. Cancer Cell Int. 2023;23(1) [Crossref]
4- Bao S, Darvishi M, H Amin A, Al-Haideri M, Patra I, Kashikova K, Ahmad I, Alsaikhan F, Al-qaim Z, Al-Gazally M, Kiasari B, Tavakoli-Far B, Sidikov A, Mustafa Y, Akhavan-Sigari R. CXC chemokine receptor 4 (CXCR4) blockade in cancer treatment. J Cancer Res Clin Oncol. 2023;149(10):7945 [Crossref]
5- Najafzadeh B, Asadzadeh Z, Motafakker Azad R, Mokhtarzadeh A, Baghbanzadeh A, Alemohammad H, Abdoli Shadbad M, Vasefifar P, Najafi S, Baradaran B. The oncogenic potential of NANOG: An important cancer induction mediator. Journal Cellular Physiology. 2021;236(4):2443 [Crossref]
6- Vasefifar P, Najafi S, Motafakkerazad R, Amini M, Safaei S, Najafzadeh B, Alemohammad H, Jafarlou M, Baradaran B. Targeting Nanog expression increased Cisplatin chemosensitivity and inhibited cell migration in Gastric cancer cells. Experimental Cell Research. 2023;429(2):113681 [Crossref]